nodes	percent_of_prediction	percent_of_DWPC	metapath
Conjugated Estrogens—prostate cancer—urinary bladder cancer	0.392	1	CtDrD
Conjugated Estrogens—ESR2—urinary bladder cancer	0.134	0.619	CbGaD
Conjugated Estrogens—ESR1—urinary bladder cancer	0.0825	0.381	CbGaD
Conjugated Estrogens—ABCC11—Methotrexate—urinary bladder cancer	0.0285	0.107	CbGbCtD
Conjugated Estrogens—SLCO3A1—Methotrexate—urinary bladder cancer	0.0196	0.0735	CbGbCtD
Conjugated Estrogens—ABCC3—Fluorouracil—urinary bladder cancer	0.0143	0.0536	CbGbCtD
Conjugated Estrogens—SLCO1C1—Methotrexate—urinary bladder cancer	0.0125	0.047	CbGbCtD
Conjugated Estrogens—ABCC3—Cisplatin—urinary bladder cancer	0.0121	0.0455	CbGbCtD
Conjugated Estrogens—ABCC3—Etoposide—urinary bladder cancer	0.0119	0.0447	CbGbCtD
Conjugated Estrogens—ABCC4—Fluorouracil—urinary bladder cancer	0.0109	0.0409	CbGbCtD
Conjugated Estrogens—ABCC1—Epirubicin—urinary bladder cancer	0.00938	0.0352	CbGbCtD
Conjugated Estrogens—ABCB1—Mitomycin—urinary bladder cancer	0.00858	0.0322	CbGbCtD
Conjugated Estrogens—ABCC3—Doxorubicin—urinary bladder cancer	0.00812	0.0305	CbGbCtD
Conjugated Estrogens—ABCC3—Methotrexate—urinary bladder cancer	0.00787	0.0295	CbGbCtD
Conjugated Estrogens—ABCC1—Etoposide—urinary bladder cancer	0.00731	0.0274	CbGbCtD
Conjugated Estrogens—SLCO1B3—Methotrexate—urinary bladder cancer	0.00699	0.0262	CbGbCtD
Conjugated Estrogens—SLC22A11—Methotrexate—urinary bladder cancer	0.00646	0.0242	CbGbCtD
Conjugated Estrogens—ABCC2—Carboplatin—urinary bladder cancer	0.00644	0.0242	CbGbCtD
Conjugated Estrogens—ABCC4—Methotrexate—urinary bladder cancer	0.00601	0.0226	CbGbCtD
Conjugated Estrogens—ABCG2—Fluorouracil—urinary bladder cancer	0.00586	0.022	CbGbCtD
Conjugated Estrogens—ABCG2—Carboplatin—urinary bladder cancer	0.00583	0.0219	CbGbCtD
Conjugated Estrogens—ABCC2—Cisplatin—urinary bladder cancer	0.00551	0.0207	CbGbCtD
Conjugated Estrogens—ABCC2—Etoposide—urinary bladder cancer	0.00541	0.0203	CbGbCtD
Conjugated Estrogens—ABCC1—Doxorubicin—urinary bladder cancer	0.00499	0.0187	CbGbCtD
Conjugated Estrogens—ABCG2—Cisplatin—urinary bladder cancer	0.00498	0.0187	CbGbCtD
Conjugated Estrogens—ABCG2—Etoposide—urinary bladder cancer	0.00489	0.0184	CbGbCtD
Conjugated Estrogens—ABCC1—Methotrexate—urinary bladder cancer	0.00483	0.0181	CbGbCtD
Conjugated Estrogens—SLCO1A2—Methotrexate—urinary bladder cancer	0.00431	0.0162	CbGbCtD
Conjugated Estrogens—SLCO1B1—Methotrexate—urinary bladder cancer	0.00407	0.0153	CbGbCtD
Conjugated Estrogens—CYP3A4—Thiotepa—urinary bladder cancer	0.0039	0.0146	CbGbCtD
Conjugated Estrogens—SLC22A8—Methotrexate—urinary bladder cancer	0.00376	0.0141	CbGbCtD
Conjugated Estrogens—ABCC2—Doxorubicin—urinary bladder cancer	0.00369	0.0139	CbGbCtD
Conjugated Estrogens—ABCC2—Methotrexate—urinary bladder cancer	0.00357	0.0134	CbGbCtD
Conjugated Estrogens—ABCG2—Doxorubicin—urinary bladder cancer	0.00334	0.0125	CbGbCtD
Conjugated Estrogens—ABCG2—Methotrexate—urinary bladder cancer	0.00323	0.0121	CbGbCtD
Conjugated Estrogens—SLC22A6—Methotrexate—urinary bladder cancer	0.00262	0.00982	CbGbCtD
Conjugated Estrogens—ABCB1—Gemcitabine—urinary bladder cancer	0.00247	0.00928	CbGbCtD
Conjugated Estrogens—CYP1A2—Fluorouracil—urinary bladder cancer	0.00242	0.00907	CbGbCtD
Conjugated Estrogens—CYP1A2—Etoposide—urinary bladder cancer	0.00202	0.00757	CbGbCtD
Conjugated Estrogens—ABCB1—Cisplatin—urinary bladder cancer	0.0018	0.00674	CbGbCtD
Conjugated Estrogens—ABCB1—Etoposide—urinary bladder cancer	0.00176	0.00662	CbGbCtD
Conjugated Estrogens—SLC51B—prostate gland—urinary bladder cancer	0.00148	0.0498	CbGeAlD
Conjugated Estrogens—ABCB1—Doxorubicin—urinary bladder cancer	0.0012	0.00452	CbGbCtD
Conjugated Estrogens—ABCB1—Methotrexate—urinary bladder cancer	0.00117	0.00438	CbGbCtD
Conjugated Estrogens—SLC51A—prostate gland—urinary bladder cancer	0.00106	0.0357	CbGeAlD
Conjugated Estrogens—CYP3A4—Etoposide—urinary bladder cancer	0.00106	0.00397	CbGbCtD
Conjugated Estrogens—SLC22A8—urine—urinary bladder cancer	0.000985	0.0332	CbGeAlD
Conjugated Estrogens—CYP3A4—Doxorubicin—urinary bladder cancer	0.000721	0.00271	CbGbCtD
Conjugated Estrogens—ABCC11—female reproductive system—urinary bladder cancer	0.000719	0.0242	CbGeAlD
Conjugated Estrogens—SLC10A1—prostate gland—urinary bladder cancer	0.000686	0.0231	CbGeAlD
Conjugated Estrogens—CYP1A2—urine—urinary bladder cancer	0.000674	0.0227	CbGeAlD
Conjugated Estrogens—SLC10A1—seminal vesicle—urinary bladder cancer	0.00058	0.0196	CbGeAlD
Conjugated Estrogens—SLC51A—female reproductive system—urinary bladder cancer	0.000578	0.0195	CbGeAlD
Conjugated Estrogens—SLCO3A1—prostate gland—urinary bladder cancer	0.000567	0.0191	CbGeAlD
Conjugated Estrogens—SLC51A—vagina—urinary bladder cancer	0.000523	0.0176	CbGeAlD
Conjugated Estrogens—SLCO4A1—prostate gland—urinary bladder cancer	0.000517	0.0174	CbGeAlD
Conjugated Estrogens—CYP3A4—urine—urinary bladder cancer	0.000488	0.0165	CbGeAlD
Conjugated Estrogens—SLCO3A1—seminal vesicle—urinary bladder cancer	0.00048	0.0162	CbGeAlD
Conjugated Estrogens—SLC10A1—renal system—urinary bladder cancer	0.000468	0.0158	CbGeAlD
Conjugated Estrogens—ESR2—prostate gland—urinary bladder cancer	0.000459	0.0155	CbGeAlD
Conjugated Estrogens—SLCO1C1—renal system—urinary bladder cancer	0.00044	0.0148	CbGeAlD
Conjugated Estrogens—SLCO4A1—seminal vesicle—urinary bladder cancer	0.000437	0.0147	CbGeAlD
Conjugated Estrogens—COMT—prostate gland—urinary bladder cancer	0.000437	0.0147	CbGeAlD
Conjugated Estrogens—ABCC3—prostate gland—urinary bladder cancer	0.000432	0.0146	CbGeAlD
Conjugated Estrogens—SLC22A11—renal system—urinary bladder cancer	0.000427	0.0144	CbGeAlD
Conjugated Estrogens—SLCO2B1—prostate gland—urinary bladder cancer	0.000402	0.0136	CbGeAlD
Conjugated Estrogens—SLCO1B3—vagina—urinary bladder cancer	0.000388	0.0131	CbGeAlD
Conjugated Estrogens—SLCO3A1—renal system—urinary bladder cancer	0.000387	0.013	CbGeAlD
Conjugated Estrogens—SLCO3A1—urethra—urinary bladder cancer	0.00038	0.0128	CbGeAlD
Conjugated Estrogens—SLC10A1—female reproductive system—urinary bladder cancer	0.000375	0.0126	CbGeAlD
Conjugated Estrogens—COMT—seminal vesicle—urinary bladder cancer	0.00037	0.0125	CbGeAlD
Conjugated Estrogens—ABCC4—prostate gland—urinary bladder cancer	0.000356	0.012	CbGeAlD
Conjugated Estrogens—SLC22A8—prostate gland—urinary bladder cancer	0.000354	0.0119	CbGeAlD
Conjugated Estrogens—SLCO4A1—renal system—urinary bladder cancer	0.000352	0.0119	CbGeAlD
Conjugated Estrogens—SLCO4A1—urethra—urinary bladder cancer	0.000346	0.0117	CbGeAlD
Conjugated Estrogens—ABCC2—prostate gland—urinary bladder cancer	0.000345	0.0116	CbGeAlD
Conjugated Estrogens—SLC22A11—female reproductive system—urinary bladder cancer	0.000342	0.0115	CbGeAlD
Conjugated Estrogens—SLC51A—lymph node—urinary bladder cancer	0.000338	0.0114	CbGeAlD
Conjugated Estrogens—ESR2—epithelium—urinary bladder cancer	0.000337	0.0114	CbGeAlD
Conjugated Estrogens—ESR2—smooth muscle tissue—urinary bladder cancer	0.000325	0.0109	CbGeAlD
Conjugated Estrogens—ESR1—prostate gland—urinary bladder cancer	0.000314	0.0106	CbGeAlD
Conjugated Estrogens—ESR2—renal system—urinary bladder cancer	0.000313	0.0105	CbGeAlD
Conjugated Estrogens—SLCO1B1—renal system—urinary bladder cancer	0.00031	0.0105	CbGeAlD
Conjugated Estrogens—SLCO3A1—female reproductive system—urinary bladder cancer	0.00031	0.0104	CbGeAlD
Conjugated Estrogens—COMT—smooth muscle tissue—urinary bladder cancer	0.000309	0.0104	CbGeAlD
Conjugated Estrogens—ABCC1—prostate gland—urinary bladder cancer	0.000304	0.0102	CbGeAlD
Conjugated Estrogens—COMT—renal system—urinary bladder cancer	0.000298	0.01	CbGeAlD
Conjugated Estrogens—ABCC3—renal system—urinary bladder cancer	0.000294	0.00992	CbGeAlD
Conjugated Estrogens—COMT—urethra—urinary bladder cancer	0.000293	0.00987	CbGeAlD
Conjugated Estrogens—Estriol—ESR2—urinary bladder cancer	0.000288	0.122	CrCbGaD
Conjugated Estrogens—SLCO4A1—female reproductive system—urinary bladder cancer	0.000282	0.00952	CbGeAlD
Conjugated Estrogens—SLCO3A1—vagina—urinary bladder cancer	0.00028	0.00945	CbGeAlD
Conjugated Estrogens—SLCO2B1—renal system—urinary bladder cancer	0.000274	0.00925	CbGeAlD
Conjugated Estrogens—Quinestrol—ESR1—urinary bladder cancer	0.000268	0.113	CrCbGaD
Conjugated Estrogens—Estramustine—ESR2—urinary bladder cancer	0.000268	0.113	CrCbGaD
Conjugated Estrogens—ABCC1—seminal vesicle—urinary bladder cancer	0.000257	0.00866	CbGeAlD
Conjugated Estrogens—SLCO4A1—vagina—urinary bladder cancer	0.000255	0.00861	CbGeAlD
Conjugated Estrogens—SLCO1A2—renal system—urinary bladder cancer	0.000252	0.00851	CbGeAlD
Conjugated Estrogens—ABCG2—prostate gland—urinary bladder cancer	0.000252	0.00848	CbGeAlD
Conjugated Estrogens—ESR2—female reproductive system—urinary bladder cancer	0.00025	0.00844	CbGeAlD
Conjugated Estrogens—SLCO1B1—female reproductive system—urinary bladder cancer	0.000248	0.00837	CbGeAlD
Conjugated Estrogens—ABCC4—renal system—urinary bladder cancer	0.000243	0.00819	CbGeAlD
Conjugated Estrogens—SLC22A8—renal system—urinary bladder cancer	0.000241	0.00812	CbGeAlD
Conjugated Estrogens—COMT—female reproductive system—urinary bladder cancer	0.000239	0.00804	CbGeAlD
Conjugated Estrogens—ABCC3—female reproductive system—urinary bladder cancer	0.000236	0.00794	CbGeAlD
Conjugated Estrogens—ABCC2—renal system—urinary bladder cancer	0.000235	0.00793	CbGeAlD
Conjugated Estrogens—ESR1—epithelium—urinary bladder cancer	0.000231	0.00778	CbGeAlD
Conjugated Estrogens—ESR2—vagina—urinary bladder cancer	0.000226	0.00763	CbGeAlD
Conjugated Estrogens—ESR1—smooth muscle tissue—urinary bladder cancer	0.000222	0.0075	CbGeAlD
Conjugated Estrogens—Estropipate—ESR2—urinary bladder cancer	0.00022	0.093	CrCbGaD
Conjugated Estrogens—SLCO2B1—female reproductive system—urinary bladder cancer	0.00022	0.00741	CbGeAlD
Conjugated Estrogens—COMT—vagina—urinary bladder cancer	0.000216	0.00728	CbGeAlD
Conjugated Estrogens—ESR1—renal system—urinary bladder cancer	0.000214	0.00722	CbGeAlD
Conjugated Estrogens—ABCG2—seminal vesicle—urinary bladder cancer	0.000213	0.00717	CbGeAlD
Conjugated Estrogens—SLCO1C1—lymph node—urinary bladder cancer	0.000206	0.00695	CbGeAlD
Conjugated Estrogens—ABCC1—urethra—urinary bladder cancer	0.000203	0.00686	CbGeAlD
Conjugated Estrogens—Mestranol—ESR1—urinary bladder cancer	0.000203	0.0858	CrCbGaD
Conjugated Estrogens—ABCC4—female reproductive system—urinary bladder cancer	0.000194	0.00656	CbGeAlD
Conjugated Estrogens—ABCC2—female reproductive system—urinary bladder cancer	0.000188	0.00635	CbGeAlD
Conjugated Estrogens—SLCO3A1—lymph node—urinary bladder cancer	0.000181	0.00611	CbGeAlD
Conjugated Estrogens—Estriol—ESR1—urinary bladder cancer	0.000177	0.0749	CrCbGaD
Conjugated Estrogens—ESR1—female reproductive system—urinary bladder cancer	0.000171	0.00578	CbGeAlD
Conjugated Estrogens—ABCG2—urethra—urinary bladder cancer	0.000168	0.00568	CbGeAlD
Conjugated Estrogens—SLCO4A1—lymph node—urinary bladder cancer	0.000165	0.00557	CbGeAlD
Conjugated Estrogens—CYP1A2—renal system—urinary bladder cancer	0.000165	0.00556	CbGeAlD
Conjugated Estrogens—Estramustine—ESR1—urinary bladder cancer	0.000165	0.0696	CrCbGaD
Conjugated Estrogens—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000157	0.0664	CrCbGaD
Conjugated Estrogens—ESR1—vagina—urinary bladder cancer	0.000155	0.00523	CbGeAlD
Conjugated Estrogens—ABCC1—vagina—urinary bladder cancer	0.00015	0.00506	CbGeAlD
Conjugated Estrogens—ESR2—lymph node—urinary bladder cancer	0.000146	0.00494	CbGeAlD
Conjugated Estrogens—COMT—lymph node—urinary bladder cancer	0.00014	0.00471	CbGeAlD
Conjugated Estrogens—ABCC3—lymph node—urinary bladder cancer	0.000138	0.00465	CbGeAlD
Conjugated Estrogens—Estrone—ESR2—urinary bladder cancer	0.000137	0.0579	CrCbGaD
Conjugated Estrogens—Estropipate—ESR1—urinary bladder cancer	0.000136	0.0573	CrCbGaD
Conjugated Estrogens—SLCO2B1—lymph node—urinary bladder cancer	0.000128	0.00433	CbGeAlD
Conjugated Estrogens—ABCG2—vagina—urinary bladder cancer	0.000124	0.00419	CbGeAlD
Conjugated Estrogens—ABCB1—prostate gland—urinary bladder cancer	0.000124	0.00418	CbGeAlD
Conjugated Estrogens—CYP3A4—renal system—urinary bladder cancer	0.000119	0.00403	CbGeAlD
Conjugated Estrogens—ABCC4—lymph node—urinary bladder cancer	0.000114	0.00384	CbGeAlD
Conjugated Estrogens—ABCC2—lymph node—urinary bladder cancer	0.00011	0.00371	CbGeAlD
Conjugated Estrogens—ABCB1—seminal vesicle—urinary bladder cancer	0.000105	0.00354	CbGeAlD
Conjugated Estrogens—Estradiol—ESR2—urinary bladder cancer	0.000104	0.0438	CrCbGaD
Conjugated Estrogens—ESR1—lymph node—urinary bladder cancer	0.0001	0.00338	CbGeAlD
Conjugated Estrogens—ABCC1—lymph node—urinary bladder cancer	9.7e-05	0.00327	CbGeAlD
Conjugated Estrogens—Ethinyl Estradiol—ESR1—urinary bladder cancer	9.69e-05	0.0409	CrCbGaD
Conjugated Estrogens—CYP3A4—female reproductive system—urinary bladder cancer	9.56e-05	0.00322	CbGeAlD
Conjugated Estrogens—ABCB1—epithelium—urinary bladder cancer	9.11e-05	0.00307	CbGeAlD
Conjugated Estrogens—ABCB1—renal system—urinary bladder cancer	8.45e-05	0.00285	CbGeAlD
Conjugated Estrogens—Estrone—ESR1—urinary bladder cancer	8.44e-05	0.0356	CrCbGaD
Conjugated Estrogens—ABCB1—urethra—urinary bladder cancer	8.3e-05	0.0028	CbGeAlD
Conjugated Estrogens—ABCG2—lymph node—urinary bladder cancer	8.03e-05	0.00271	CbGeAlD
Conjugated Estrogens—ABCB1—female reproductive system—urinary bladder cancer	6.77e-05	0.00228	CbGeAlD
Conjugated Estrogens—Estradiol—ESR1—urinary bladder cancer	6.4e-05	0.027	CrCbGaD
Conjugated Estrogens—ABCB1—vagina—urinary bladder cancer	6.12e-05	0.00206	CbGeAlD
Conjugated Estrogens—ABCB1—lymph node—urinary bladder cancer	3.96e-05	0.00134	CbGeAlD
Conjugated Estrogens—Decreased appetite—Etoposide—urinary bladder cancer	3.59e-05	0.000596	CcSEcCtD
Conjugated Estrogens—Renal failure—Epirubicin—urinary bladder cancer	3.56e-05	0.000592	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Etoposide—urinary bladder cancer	3.56e-05	0.000592	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Cisplatin—urinary bladder cancer	3.56e-05	0.000591	CcSEcCtD
Conjugated Estrogens—Fatigue—Etoposide—urinary bladder cancer	3.56e-05	0.000591	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Epirubicin—urinary bladder cancer	3.55e-05	0.00059	CcSEcCtD
Conjugated Estrogens—Constipation—Etoposide—urinary bladder cancer	3.53e-05	0.000586	CcSEcCtD
Conjugated Estrogens—Pain—Etoposide—urinary bladder cancer	3.53e-05	0.000586	CcSEcCtD
Conjugated Estrogens—Dysuria—Doxorubicin—urinary bladder cancer	3.52e-05	0.000585	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Fluorouracil—urinary bladder cancer	3.5e-05	0.000581	CcSEcCtD
Conjugated Estrogens—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	3.5e-05	0.000581	CcSEcCtD
Conjugated Estrogens—Asthenia—Gemcitabine—urinary bladder cancer	3.47e-05	0.000576	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Methotrexate—urinary bladder cancer	3.45e-05	0.000573	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Epirubicin—urinary bladder cancer	3.43e-05	0.00057	CcSEcCtD
Conjugated Estrogens—Weight increased—Doxorubicin—urinary bladder cancer	3.42e-05	0.000569	CcSEcCtD
Conjugated Estrogens—Pruritus—Gemcitabine—urinary bladder cancer	3.42e-05	0.000568	CcSEcCtD
Conjugated Estrogens—Nausea—Thiotepa—urinary bladder cancer	3.41e-05	0.000567	CcSEcCtD
Conjugated Estrogens—Sinusitis—Epirubicin—urinary bladder cancer	3.4e-05	0.000565	CcSEcCtD
Conjugated Estrogens—Hyperglycaemia—Doxorubicin—urinary bladder cancer	3.39e-05	0.000564	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Etoposide—urinary bladder cancer	3.37e-05	0.00056	CcSEcCtD
Conjugated Estrogens—Pruritus—Fluorouracil—urinary bladder cancer	3.36e-05	0.000558	CcSEcCtD
Conjugated Estrogens—Infestation NOS—Doxorubicin—urinary bladder cancer	3.35e-05	0.000557	CcSEcCtD
Conjugated Estrogens—Infestation—Doxorubicin—urinary bladder cancer	3.35e-05	0.000557	CcSEcCtD
Conjugated Estrogens—Visual impairment—Methotrexate—urinary bladder cancer	3.35e-05	0.000557	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Cisplatin—urinary bladder cancer	3.32e-05	0.000551	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Gemcitabine—urinary bladder cancer	3.3e-05	0.000549	CcSEcCtD
Conjugated Estrogens—Renal failure—Doxorubicin—urinary bladder cancer	3.3e-05	0.000548	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Methotrexate—urinary bladder cancer	3.29e-05	0.000546	CcSEcCtD
Conjugated Estrogens—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	3.29e-05	0.000546	CcSEcCtD
Conjugated Estrogens—Urticaria—Etoposide—urinary bladder cancer	3.28e-05	0.000544	CcSEcCtD
Conjugated Estrogens—Rhinitis—Epirubicin—urinary bladder cancer	3.26e-05	0.000542	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Etoposide—urinary bladder cancer	3.26e-05	0.000542	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Etoposide—urinary bladder cancer	3.26e-05	0.000542	CcSEcCtD
Conjugated Estrogens—Eye disorder—Methotrexate—urinary bladder cancer	3.25e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Fluorouracil—urinary bladder cancer	3.25e-05	0.00054	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Epirubicin—urinary bladder cancer	3.24e-05	0.000538	CcSEcCtD
Conjugated Estrogens—Asthenia—Cisplatin—urinary bladder cancer	3.23e-05	0.000537	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Epirubicin—urinary bladder cancer	3.23e-05	0.000537	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Methotrexate—urinary bladder cancer	3.23e-05	0.000536	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Epirubicin—urinary bladder cancer	3.21e-05	0.000533	CcSEcCtD
Conjugated Estrogens—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	3.17e-05	0.000527	CcSEcCtD
Conjugated Estrogens—Angiopathy—Methotrexate—urinary bladder cancer	3.15e-05	0.000524	CcSEcCtD
Conjugated Estrogens—Sinusitis—Doxorubicin—urinary bladder cancer	3.15e-05	0.000523	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Methotrexate—urinary bladder cancer	3.14e-05	0.000522	CcSEcCtD
Conjugated Estrogens—Dizziness—Fluorouracil—urinary bladder cancer	3.14e-05	0.000522	CcSEcCtD
Conjugated Estrogens—Visual impairment—Epirubicin—urinary bladder cancer	3.14e-05	0.000521	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Methotrexate—urinary bladder cancer	3.13e-05	0.000521	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Cisplatin—urinary bladder cancer	3.08e-05	0.000512	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Epirubicin—urinary bladder cancer	3.08e-05	0.000511	CcSEcCtD
Conjugated Estrogens—Alopecia—Methotrexate—urinary bladder cancer	3.07e-05	0.000511	CcSEcCtD
Conjugated Estrogens—Vomiting—Gemcitabine—urinary bladder cancer	3.07e-05	0.00051	CcSEcCtD
Conjugated Estrogens—Mental disorder—Methotrexate—urinary bladder cancer	3.05e-05	0.000506	CcSEcCtD
Conjugated Estrogens—Rash—Gemcitabine—urinary bladder cancer	3.05e-05	0.000506	CcSEcCtD
Conjugated Estrogens—Dermatitis—Gemcitabine—urinary bladder cancer	3.04e-05	0.000506	CcSEcCtD
Conjugated Estrogens—Eye disorder—Epirubicin—urinary bladder cancer	3.04e-05	0.000505	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Etoposide—urinary bladder cancer	3.04e-05	0.000505	CcSEcCtD
Conjugated Estrogens—Malnutrition—Methotrexate—urinary bladder cancer	3.03e-05	0.000503	CcSEcCtD
Conjugated Estrogens—Erythema—Methotrexate—urinary bladder cancer	3.03e-05	0.000503	CcSEcCtD
Conjugated Estrogens—Headache—Gemcitabine—urinary bladder cancer	3.03e-05	0.000503	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Epirubicin—urinary bladder cancer	3.02e-05	0.000502	CcSEcCtD
Conjugated Estrogens—Vomiting—Fluorouracil—urinary bladder cancer	3.02e-05	0.000502	CcSEcCtD
Conjugated Estrogens—Rhinitis—Doxorubicin—urinary bladder cancer	3.02e-05	0.000502	CcSEcCtD
Conjugated Estrogens—Hypoaesthesia—Doxorubicin—urinary bladder cancer	3e-05	0.000498	CcSEcCtD
Conjugated Estrogens—Rash—Fluorouracil—urinary bladder cancer	2.99e-05	0.000498	CcSEcCtD
Conjugated Estrogens—Dermatitis—Fluorouracil—urinary bladder cancer	2.99e-05	0.000497	CcSEcCtD
Conjugated Estrogens—Pharyngitis—Doxorubicin—urinary bladder cancer	2.99e-05	0.000497	CcSEcCtD
Conjugated Estrogens—Headache—Fluorouracil—urinary bladder cancer	2.97e-05	0.000494	CcSEcCtD
Conjugated Estrogens—Oedema peripheral—Doxorubicin—urinary bladder cancer	2.97e-05	0.000493	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Methotrexate—urinary bladder cancer	2.96e-05	0.000493	CcSEcCtD
Conjugated Estrogens—Asthenia—Etoposide—urinary bladder cancer	2.96e-05	0.000492	CcSEcCtD
Conjugated Estrogens—Angiopathy—Epirubicin—urinary bladder cancer	2.95e-05	0.000491	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Epirubicin—urinary bladder cancer	2.94e-05	0.000488	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Epirubicin—urinary bladder cancer	2.93e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Back pain—Methotrexate—urinary bladder cancer	2.93e-05	0.000487	CcSEcCtD
Conjugated Estrogens—Pruritus—Etoposide—urinary bladder cancer	2.92e-05	0.000485	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Epirubicin—urinary bladder cancer	2.91e-05	0.000483	CcSEcCtD
Conjugated Estrogens—Visual impairment—Doxorubicin—urinary bladder cancer	2.9e-05	0.000482	CcSEcCtD
Conjugated Estrogens—Alopecia—Epirubicin—urinary bladder cancer	2.88e-05	0.000478	CcSEcCtD
Conjugated Estrogens—Nausea—Gemcitabine—urinary bladder cancer	2.87e-05	0.000477	CcSEcCtD
Conjugated Estrogens—Vomiting—Cisplatin—urinary bladder cancer	2.86e-05	0.000476	CcSEcCtD
Conjugated Estrogens—Vision blurred—Methotrexate—urinary bladder cancer	2.85e-05	0.000474	CcSEcCtD
Conjugated Estrogens—Mental disorder—Epirubicin—urinary bladder cancer	2.85e-05	0.000474	CcSEcCtD
Conjugated Estrogens—Erythema multiforme—Doxorubicin—urinary bladder cancer	2.85e-05	0.000473	CcSEcCtD
Conjugated Estrogens—Rash—Cisplatin—urinary bladder cancer	2.84e-05	0.000472	CcSEcCtD
Conjugated Estrogens—Dermatitis—Cisplatin—urinary bladder cancer	2.84e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Malnutrition—Epirubicin—urinary bladder cancer	2.83e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Erythema—Epirubicin—urinary bladder cancer	2.83e-05	0.000471	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Etoposide—urinary bladder cancer	2.82e-05	0.000469	CcSEcCtD
Conjugated Estrogens—Nausea—Fluorouracil—urinary bladder cancer	2.82e-05	0.000469	CcSEcCtD
Conjugated Estrogens—Eye disorder—Doxorubicin—urinary bladder cancer	2.81e-05	0.000468	CcSEcCtD
Conjugated Estrogens—Cardiac disorder—Doxorubicin—urinary bladder cancer	2.79e-05	0.000464	CcSEcCtD
Conjugated Estrogens—Flatulence—Epirubicin—urinary bladder cancer	2.79e-05	0.000464	CcSEcCtD
Conjugated Estrogens—Tension—Epirubicin—urinary bladder cancer	2.78e-05	0.000462	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Epirubicin—urinary bladder cancer	2.77e-05	0.000461	CcSEcCtD
Conjugated Estrogens—Nervousness—Epirubicin—urinary bladder cancer	2.75e-05	0.000457	CcSEcCtD
Conjugated Estrogens—Back pain—Epirubicin—urinary bladder cancer	2.74e-05	0.000455	CcSEcCtD
Conjugated Estrogens—Angiopathy—Doxorubicin—urinary bladder cancer	2.73e-05	0.000454	CcSEcCtD
Conjugated Estrogens—Dizziness—Etoposide—urinary bladder cancer	2.73e-05	0.000453	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Epirubicin—urinary bladder cancer	2.72e-05	0.000453	CcSEcCtD
Conjugated Estrogens—Immune system disorder—Doxorubicin—urinary bladder cancer	2.72e-05	0.000452	CcSEcCtD
Conjugated Estrogens—Vertigo—Methotrexate—urinary bladder cancer	2.72e-05	0.000452	CcSEcCtD
Conjugated Estrogens—Mediastinal disorder—Doxorubicin—urinary bladder cancer	2.71e-05	0.000451	CcSEcCtD
Conjugated Estrogens—Arrhythmia—Doxorubicin—urinary bladder cancer	2.69e-05	0.000447	CcSEcCtD
Conjugated Estrogens—Nausea—Cisplatin—urinary bladder cancer	2.67e-05	0.000444	CcSEcCtD
Conjugated Estrogens—Vision blurred—Epirubicin—urinary bladder cancer	2.67e-05	0.000444	CcSEcCtD
Conjugated Estrogens—Alopecia—Doxorubicin—urinary bladder cancer	2.66e-05	0.000442	CcSEcCtD
Conjugated Estrogens—Cough—Methotrexate—urinary bladder cancer	2.64e-05	0.000439	CcSEcCtD
Conjugated Estrogens—Mental disorder—Doxorubicin—urinary bladder cancer	2.64e-05	0.000438	CcSEcCtD
Conjugated Estrogens—Convulsion—Methotrexate—urinary bladder cancer	2.62e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Vomiting—Etoposide—urinary bladder cancer	2.62e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Malnutrition—Doxorubicin—urinary bladder cancer	2.62e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Erythema—Doxorubicin—urinary bladder cancer	2.62e-05	0.000436	CcSEcCtD
Conjugated Estrogens—Rash—Etoposide—urinary bladder cancer	2.6e-05	0.000432	CcSEcCtD
Conjugated Estrogens—Dermatitis—Etoposide—urinary bladder cancer	2.6e-05	0.000432	CcSEcCtD
Conjugated Estrogens—Headache—Etoposide—urinary bladder cancer	2.58e-05	0.000429	CcSEcCtD
Conjugated Estrogens—Flatulence—Doxorubicin—urinary bladder cancer	2.58e-05	0.000429	CcSEcCtD
Conjugated Estrogens—Myalgia—Methotrexate—urinary bladder cancer	2.58e-05	0.000428	CcSEcCtD
Conjugated Estrogens—Chest pain—Methotrexate—urinary bladder cancer	2.58e-05	0.000428	CcSEcCtD
Conjugated Estrogens—Arthralgia—Methotrexate—urinary bladder cancer	2.58e-05	0.000428	CcSEcCtD
Conjugated Estrogens—Tension—Doxorubicin—urinary bladder cancer	2.57e-05	0.000427	CcSEcCtD
Conjugated Estrogens—Dysgeusia—Doxorubicin—urinary bladder cancer	2.57e-05	0.000427	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	2.56e-05	0.000425	CcSEcCtD
Conjugated Estrogens—Nervousness—Doxorubicin—urinary bladder cancer	2.55e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Vertigo—Epirubicin—urinary bladder cancer	2.54e-05	0.000423	CcSEcCtD
Conjugated Estrogens—Syncope—Epirubicin—urinary bladder cancer	2.54e-05	0.000422	CcSEcCtD
Conjugated Estrogens—Back pain—Doxorubicin—urinary bladder cancer	2.54e-05	0.000421	CcSEcCtD
Conjugated Estrogens—Muscle spasms—Doxorubicin—urinary bladder cancer	2.52e-05	0.000419	CcSEcCtD
Conjugated Estrogens—Palpitations—Epirubicin—urinary bladder cancer	2.5e-05	0.000416	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Epirubicin—urinary bladder cancer	2.49e-05	0.000414	CcSEcCtD
Conjugated Estrogens—Cough—Epirubicin—urinary bladder cancer	2.47e-05	0.000411	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Methotrexate—urinary bladder cancer	2.47e-05	0.000411	CcSEcCtD
Conjugated Estrogens—Vision blurred—Doxorubicin—urinary bladder cancer	2.47e-05	0.00041	CcSEcCtD
Conjugated Estrogens—Convulsion—Epirubicin—urinary bladder cancer	2.45e-05	0.000408	CcSEcCtD
Conjugated Estrogens—Infection—Methotrexate—urinary bladder cancer	2.45e-05	0.000408	CcSEcCtD
Conjugated Estrogens—Nausea—Etoposide—urinary bladder cancer	2.45e-05	0.000407	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Methotrexate—urinary bladder cancer	2.42e-05	0.000403	CcSEcCtD
Conjugated Estrogens—Chest pain—Epirubicin—urinary bladder cancer	2.41e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Arthralgia—Epirubicin—urinary bladder cancer	2.41e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Myalgia—Epirubicin—urinary bladder cancer	2.41e-05	0.000401	CcSEcCtD
Conjugated Estrogens—Anxiety—Epirubicin—urinary bladder cancer	2.4e-05	0.000399	CcSEcCtD
Conjugated Estrogens—Skin disorder—Methotrexate—urinary bladder cancer	2.4e-05	0.000399	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	2.39e-05	0.000398	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Methotrexate—urinary bladder cancer	2.39e-05	0.000397	CcSEcCtD
Conjugated Estrogens—Vertigo—Doxorubicin—urinary bladder cancer	2.35e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Anorexia—Methotrexate—urinary bladder cancer	2.35e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Syncope—Doxorubicin—urinary bladder cancer	2.35e-05	0.000391	CcSEcCtD
Conjugated Estrogens—Palpitations—Doxorubicin—urinary bladder cancer	2.32e-05	0.000385	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Epirubicin—urinary bladder cancer	2.31e-05	0.000384	CcSEcCtD
Conjugated Estrogens—Oedema—Epirubicin—urinary bladder cancer	2.31e-05	0.000384	CcSEcCtD
Conjugated Estrogens—Hypotension—Methotrexate—urinary bladder cancer	2.31e-05	0.000384	CcSEcCtD
Conjugated Estrogens—Loss of consciousness—Doxorubicin—urinary bladder cancer	2.3e-05	0.000383	CcSEcCtD
Conjugated Estrogens—Infection—Epirubicin—urinary bladder cancer	2.3e-05	0.000382	CcSEcCtD
Conjugated Estrogens—Cough—Doxorubicin—urinary bladder cancer	2.29e-05	0.00038	CcSEcCtD
Conjugated Estrogens—Shock—Epirubicin—urinary bladder cancer	2.27e-05	0.000378	CcSEcCtD
Conjugated Estrogens—Convulsion—Doxorubicin—urinary bladder cancer	2.27e-05	0.000377	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Epirubicin—urinary bladder cancer	2.27e-05	0.000377	CcSEcCtD
Conjugated Estrogens—Tachycardia—Epirubicin—urinary bladder cancer	2.26e-05	0.000375	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	2.25e-05	0.000374	CcSEcCtD
Conjugated Estrogens—Skin disorder—Epirubicin—urinary bladder cancer	2.25e-05	0.000373	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Epirubicin—urinary bladder cancer	2.23e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Insomnia—Methotrexate—urinary bladder cancer	2.23e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Arthralgia—Doxorubicin—urinary bladder cancer	2.23e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Chest pain—Doxorubicin—urinary bladder cancer	2.23e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Myalgia—Doxorubicin—urinary bladder cancer	2.23e-05	0.000371	CcSEcCtD
Conjugated Estrogens—Anxiety—Doxorubicin—urinary bladder cancer	2.22e-05	0.00037	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Methotrexate—urinary bladder cancer	2.22e-05	0.000369	CcSEcCtD
Conjugated Estrogens—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	2.22e-05	0.000368	CcSEcCtD
Conjugated Estrogens—Anorexia—Epirubicin—urinary bladder cancer	2.2e-05	0.000366	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Methotrexate—urinary bladder cancer	2.2e-05	0.000366	CcSEcCtD
Conjugated Estrogens—Somnolence—Methotrexate—urinary bladder cancer	2.2e-05	0.000365	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Methotrexate—urinary bladder cancer	2.17e-05	0.000361	CcSEcCtD
Conjugated Estrogens—Hypotension—Epirubicin—urinary bladder cancer	2.16e-05	0.000359	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Methotrexate—urinary bladder cancer	2.15e-05	0.000357	CcSEcCtD
Conjugated Estrogens—Oedema—Doxorubicin—urinary bladder cancer	2.14e-05	0.000355	CcSEcCtD
Conjugated Estrogens—Anaphylactic shock—Doxorubicin—urinary bladder cancer	2.14e-05	0.000355	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	2.13e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Fatigue—Methotrexate—urinary bladder cancer	2.13e-05	0.000354	CcSEcCtD
Conjugated Estrogens—Infection—Doxorubicin—urinary bladder cancer	2.13e-05	0.000353	CcSEcCtD
Conjugated Estrogens—Pain—Methotrexate—urinary bladder cancer	2.11e-05	0.000351	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	2.11e-05	0.00035	CcSEcCtD
Conjugated Estrogens—Shock—Doxorubicin—urinary bladder cancer	2.1e-05	0.00035	CcSEcCtD
Conjugated Estrogens—Nervous system disorder—Doxorubicin—urinary bladder cancer	2.1e-05	0.000349	CcSEcCtD
Conjugated Estrogens—Insomnia—Epirubicin—urinary bladder cancer	2.09e-05	0.000347	CcSEcCtD
Conjugated Estrogens—Tachycardia—Doxorubicin—urinary bladder cancer	2.09e-05	0.000347	CcSEcCtD
Conjugated Estrogens—Skin disorder—Doxorubicin—urinary bladder cancer	2.08e-05	0.000345	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Epirubicin—urinary bladder cancer	2.08e-05	0.000345	CcSEcCtD
Conjugated Estrogens—Hyperhidrosis—Doxorubicin—urinary bladder cancer	2.07e-05	0.000344	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Epirubicin—urinary bladder cancer	2.06e-05	0.000342	CcSEcCtD
Conjugated Estrogens—Somnolence—Epirubicin—urinary bladder cancer	2.06e-05	0.000342	CcSEcCtD
Conjugated Estrogens—Anorexia—Doxorubicin—urinary bladder cancer	2.04e-05	0.000339	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Epirubicin—urinary bladder cancer	2.03e-05	0.000338	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Methotrexate—urinary bladder cancer	2.02e-05	0.000336	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Epirubicin—urinary bladder cancer	2.01e-05	0.000334	CcSEcCtD
Conjugated Estrogens—Hypotension—Doxorubicin—urinary bladder cancer	2e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2e-05	0.000332	CcSEcCtD
Conjugated Estrogens—Fatigue—Epirubicin—urinary bladder cancer	1.99e-05	0.000331	CcSEcCtD
Conjugated Estrogens—Pain—Epirubicin—urinary bladder cancer	1.98e-05	0.000329	CcSEcCtD
Conjugated Estrogens—Constipation—Epirubicin—urinary bladder cancer	1.98e-05	0.000329	CcSEcCtD
Conjugated Estrogens—Urticaria—Methotrexate—urinary bladder cancer	1.96e-05	0.000326	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Methotrexate—urinary bladder cancer	1.95e-05	0.000325	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Methotrexate—urinary bladder cancer	1.95e-05	0.000325	CcSEcCtD
Conjugated Estrogens—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	1.95e-05	0.000324	CcSEcCtD
Conjugated Estrogens—Insomnia—Doxorubicin—urinary bladder cancer	1.93e-05	0.000321	CcSEcCtD
Conjugated Estrogens—Paraesthesia—Doxorubicin—urinary bladder cancer	1.92e-05	0.000319	CcSEcCtD
Conjugated Estrogens—Dyspnoea—Doxorubicin—urinary bladder cancer	1.91e-05	0.000317	CcSEcCtD
Conjugated Estrogens—Somnolence—Doxorubicin—urinary bladder cancer	1.9e-05	0.000316	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Epirubicin—urinary bladder cancer	1.89e-05	0.000314	CcSEcCtD
Conjugated Estrogens—Dyspepsia—Doxorubicin—urinary bladder cancer	1.88e-05	0.000313	CcSEcCtD
Conjugated Estrogens—Decreased appetite—Doxorubicin—urinary bladder cancer	1.86e-05	0.000309	CcSEcCtD
Conjugated Estrogens—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	1.85e-05	0.000307	CcSEcCtD
Conjugated Estrogens—Fatigue—Doxorubicin—urinary bladder cancer	1.84e-05	0.000306	CcSEcCtD
Conjugated Estrogens—Urticaria—Epirubicin—urinary bladder cancer	1.84e-05	0.000305	CcSEcCtD
Conjugated Estrogens—Pain—Doxorubicin—urinary bladder cancer	1.83e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Constipation—Doxorubicin—urinary bladder cancer	1.83e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Epirubicin—urinary bladder cancer	1.83e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Epirubicin—urinary bladder cancer	1.83e-05	0.000304	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Methotrexate—urinary bladder cancer	1.82e-05	0.000302	CcSEcCtD
Conjugated Estrogens—Asthenia—Methotrexate—urinary bladder cancer	1.77e-05	0.000295	CcSEcCtD
Conjugated Estrogens—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	1.75e-05	0.000291	CcSEcCtD
Conjugated Estrogens—Pruritus—Methotrexate—urinary bladder cancer	1.75e-05	0.00029	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Epirubicin—urinary bladder cancer	1.7e-05	0.000283	CcSEcCtD
Conjugated Estrogens—Urticaria—Doxorubicin—urinary bladder cancer	1.7e-05	0.000282	CcSEcCtD
Conjugated Estrogens—Abdominal pain—Doxorubicin—urinary bladder cancer	1.69e-05	0.000281	CcSEcCtD
Conjugated Estrogens—Body temperature increased—Doxorubicin—urinary bladder cancer	1.69e-05	0.000281	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Methotrexate—urinary bladder cancer	1.69e-05	0.000281	CcSEcCtD
Conjugated Estrogens—Asthenia—Epirubicin—urinary bladder cancer	1.66e-05	0.000276	CcSEcCtD
Conjugated Estrogens—Pruritus—Epirubicin—urinary bladder cancer	1.64e-05	0.000272	CcSEcCtD
Conjugated Estrogens—Dizziness—Methotrexate—urinary bladder cancer	1.63e-05	0.000271	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Epirubicin—urinary bladder cancer	1.58e-05	0.000263	CcSEcCtD
Conjugated Estrogens—Hypersensitivity—Doxorubicin—urinary bladder cancer	1.58e-05	0.000262	CcSEcCtD
Conjugated Estrogens—Vomiting—Methotrexate—urinary bladder cancer	1.57e-05	0.000261	CcSEcCtD
Conjugated Estrogens—Rash—Methotrexate—urinary bladder cancer	1.56e-05	0.000259	CcSEcCtD
Conjugated Estrogens—Dermatitis—Methotrexate—urinary bladder cancer	1.56e-05	0.000259	CcSEcCtD
Conjugated Estrogens—Headache—Methotrexate—urinary bladder cancer	1.55e-05	0.000257	CcSEcCtD
Conjugated Estrogens—Asthenia—Doxorubicin—urinary bladder cancer	1.53e-05	0.000255	CcSEcCtD
Conjugated Estrogens—Dizziness—Epirubicin—urinary bladder cancer	1.53e-05	0.000254	CcSEcCtD
Conjugated Estrogens—Pruritus—Doxorubicin—urinary bladder cancer	1.51e-05	0.000251	CcSEcCtD
Conjugated Estrogens—Vomiting—Epirubicin—urinary bladder cancer	1.47e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Nausea—Methotrexate—urinary bladder cancer	1.47e-05	0.000244	CcSEcCtD
Conjugated Estrogens—Diarrhoea—Doxorubicin—urinary bladder cancer	1.46e-05	0.000243	CcSEcCtD
Conjugated Estrogens—Rash—Epirubicin—urinary bladder cancer	1.46e-05	0.000242	CcSEcCtD
Conjugated Estrogens—Dermatitis—Epirubicin—urinary bladder cancer	1.46e-05	0.000242	CcSEcCtD
Conjugated Estrogens—Headache—Epirubicin—urinary bladder cancer	1.45e-05	0.000241	CcSEcCtD
Conjugated Estrogens—Dizziness—Doxorubicin—urinary bladder cancer	1.41e-05	0.000235	CcSEcCtD
Conjugated Estrogens—Nausea—Epirubicin—urinary bladder cancer	1.37e-05	0.000228	CcSEcCtD
Conjugated Estrogens—Vomiting—Doxorubicin—urinary bladder cancer	1.36e-05	0.000226	CcSEcCtD
Conjugated Estrogens—Rash—Doxorubicin—urinary bladder cancer	1.35e-05	0.000224	CcSEcCtD
Conjugated Estrogens—Dermatitis—Doxorubicin—urinary bladder cancer	1.35e-05	0.000224	CcSEcCtD
Conjugated Estrogens—Headache—Doxorubicin—urinary bladder cancer	1.34e-05	0.000223	CcSEcCtD
Conjugated Estrogens—Nausea—Doxorubicin—urinary bladder cancer	1.27e-05	0.000211	CcSEcCtD
Conjugated Estrogens—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.85e-06	0.000178	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	5.83e-06	0.000177	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	5.8e-06	0.000176	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.78e-06	0.000175	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.78e-06	0.000175	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	5.71e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	5.7e-06	0.000173	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	5.68e-06	0.000172	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—TYMS—urinary bladder cancer	5.63e-06	0.000171	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ENO2—urinary bladder cancer	5.61e-06	0.00017	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—HPGDS—urinary bladder cancer	5.61e-06	0.00017	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GSTM1—urinary bladder cancer	5.57e-06	0.000169	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—NCOR1—urinary bladder cancer	5.57e-06	0.000169	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.54e-06	0.000168	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.54e-06	0.000168	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	5.52e-06	0.000168	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NAT1—urinary bladder cancer	5.52e-06	0.000168	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.5e-06	0.000167	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GSTP1—urinary bladder cancer	5.47e-06	0.000166	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—EP300—urinary bladder cancer	5.46e-06	0.000166	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GSTT1—urinary bladder cancer	5.44e-06	0.000165	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	5.43e-06	0.000165	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	5.38e-06	0.000163	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—GPX1—urinary bladder cancer	5.33e-06	0.000162	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—SRC—urinary bladder cancer	5.31e-06	0.000161	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.29e-06	0.00016	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PRSS3—urinary bladder cancer	5.24e-06	0.000159	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—ERCC2—urinary bladder cancer	5.23e-06	0.000159	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NQO1—urinary bladder cancer	5.13e-06	0.000156	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	5.13e-06	0.000156	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.09e-06	0.000154	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—TYMS—urinary bladder cancer	5.08e-06	0.000154	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.05e-06	0.000153	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GSTM1—urinary bladder cancer	5.02e-06	0.000152	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—NCOR1—urinary bladder cancer	5.02e-06	0.000152	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PTGS2—urinary bladder cancer	5.01e-06	0.000152	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.98e-06	0.000151	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	4.96e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	4.95e-06	0.00015	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—MTHFR—urinary bladder cancer	4.92e-06	0.000149	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PPARG—urinary bladder cancer	4.88e-06	0.000148	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NQO1—urinary bladder cancer	4.88e-06	0.000148	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.83e-06	0.000146	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—GPX1—urinary bladder cancer	4.81e-06	0.000146	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	4.76e-06	0.000144	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.73e-06	0.000144	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—ERCC2—urinary bladder cancer	4.72e-06	0.000143	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	4.72e-06	0.000143	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—NCOR1—urinary bladder cancer	4.7e-06	0.000143	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—CREBBP—urinary bladder cancer	4.69e-06	0.000142	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.6e-06	0.00014	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	4.59e-06	0.000139	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—NCOR1—urinary bladder cancer	4.55e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	4.55e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	4.54e-06	0.000138	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NQO1—urinary bladder cancer	4.52e-06	0.000137	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.5e-06	0.000136	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—MTHFR—urinary bladder cancer	4.44e-06	0.000135	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	4.42e-06	0.000134	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERCC2—urinary bladder cancer	4.42e-06	0.000134	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—KRAS—urinary bladder cancer	4.4e-06	0.000133	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	4.37e-06	0.000133	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	4.37e-06	0.000133	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—PTEN—urinary bladder cancer	4.37e-06	0.000133	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.34e-06	0.000132	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.3e-06	0.00013	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GSTP1—urinary bladder cancer	4.28e-06	0.00013	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—ERCC2—urinary bladder cancer	4.28e-06	0.00013	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	4.27e-06	0.000129	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.26e-06	0.000129	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.26e-06	0.000129	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMP—urinary bladder cancer	4.19e-06	0.000127	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	4.19e-06	0.000127	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.19e-06	0.000127	CbGpPWpGaD
Conjugated Estrogens—SLC10A1—Metabolism—EP300—urinary bladder cancer	4.17e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MTHFR—urinary bladder cancer	4.15e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.14e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—TERT—urinary bladder cancer	4.14e-06	0.000126	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.13e-06	0.000125	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	4.11e-06	0.000125	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	4.11e-06	0.000125	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GSTP1—urinary bladder cancer	4.07e-06	0.000123	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	4.06e-06	0.000123	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	4.02e-06	0.000122	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PPARG—urinary bladder cancer	3.99e-06	0.000121	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—TYMS—urinary bladder cancer	3.98e-06	0.000121	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.94e-06	0.000119	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GSTM1—urinary bladder cancer	3.94e-06	0.000119	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—NCOR1—urinary bladder cancer	3.94e-06	0.000119	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—TP53—urinary bladder cancer	3.91e-06	0.000119	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	3.9e-06	0.000118	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	3.87e-06	0.000117	CbGpPWpGaD
Conjugated Estrogens—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	3.86e-06	0.000117	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTGS2—urinary bladder cancer	3.84e-06	0.000116	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—CREBBP—urinary bladder cancer	3.83e-06	0.000116	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	3.83e-06	0.000116	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	3.8e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—FGFR3—urinary bladder cancer	3.8e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NAT2—urinary bladder cancer	3.79e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—TYMS—urinary bladder cancer	3.78e-06	0.000115	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—GPX1—urinary bladder cancer	3.77e-06	0.000114	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GSTP1—urinary bladder cancer	3.77e-06	0.000114	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	3.74e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	3.74e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—ABCC4—Hemostasis—HRAS—urinary bladder cancer	3.74e-06	0.000113	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—ERCC2—urinary bladder cancer	3.7e-06	0.000112	CbGpPWpGaD
Conjugated Estrogens—ESR2—Gene Expression—MYC—urinary bladder cancer	3.69e-06	0.000112	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PPARG—urinary bladder cancer	3.6e-06	0.000109	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	3.58e-06	0.000109	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	3.52e-06	0.000107	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.51e-06	0.000106	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—TYMS—urinary bladder cancer	3.5e-06	0.000106	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—MTHFR—urinary bladder cancer	3.48e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—NCOR1—urinary bladder cancer	3.46e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GSTM1—urinary bladder cancer	3.46e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—CREBBP—urinary bladder cancer	3.46e-06	0.000105	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	3.38e-06	0.000102	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.36e-06	0.000102	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—PTEN—urinary bladder cancer	3.35e-06	0.000102	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.35e-06	0.000101	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—GPX1—urinary bladder cancer	3.32e-06	0.000101	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.32e-06	0.000101	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	3.31e-06	0.0001	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—S100B—urinary bladder cancer	3.29e-06	9.98e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—RRM2—urinary bladder cancer	3.27e-06	9.92e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—PPARG—urinary bladder cancer	3.26e-06	9.89e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—ERCC2—urinary bladder cancer	3.26e-06	9.87e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CREBBP—urinary bladder cancer	3.24e-06	9.81e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.23e-06	9.8e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.21e-06	9.75e-05	CbGpPWpGaD
Conjugated Estrogens—COMT—Metabolism—EP300—urinary bladder cancer	3.19e-06	9.69e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTGS2—urinary bladder cancer	3.14e-06	9.52e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	3.13e-06	9.51e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—CREBBP—urinary bladder cancer	3.13e-06	9.5e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—MTHFR—urinary bladder cancer	3.06e-06	9.28e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—HPGDS—urinary bladder cancer	3.03e-06	9.19e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ENO2—urinary bladder cancer	3.03e-06	9.19e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.03e-06	9.18e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	3.01e-06	9.13e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.96e-06	8.97e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.94e-06	8.91e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—RHOA—urinary bladder cancer	2.93e-06	8.88e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTGS2—urinary bladder cancer	2.83e-06	8.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PPARG—urinary bladder cancer	2.82e-06	8.55e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.75e-06	8.35e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—PTEN—urinary bladder cancer	2.74e-06	8.3e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—CREBBP—urinary bladder cancer	2.71e-06	8.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—ERBB2—urinary bladder cancer	2.71e-06	8.22e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	2.68e-06	8.13e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTGS2—urinary bladder cancer	2.65e-06	8.03e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.61e-06	7.92e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B3—Metabolism—EP300—urinary bladder cancer	2.61e-06	7.92e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TERT—urinary bladder cancer	2.61e-06	7.91e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.58e-06	7.83e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	2.57e-06	7.81e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PPARG—urinary bladder cancer	2.48e-06	7.53e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—PTEN—urinary bladder cancer	2.47e-06	7.49e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	2.47e-06	7.48e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NQO1—urinary bladder cancer	2.44e-06	7.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.42e-06	7.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.42e-06	7.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.41e-06	7.29e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	2.39e-06	7.26e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—CREBBP—urinary bladder cancer	2.38e-06	7.23e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC3—Metabolism—EP300—urinary bladder cancer	2.36e-06	7.14e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.35e-06	7.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.34e-06	7.08e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—CDKN1A—urinary bladder cancer	2.32e-06	7.02e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.31e-06	7.01e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—PTEN—urinary bladder cancer	2.31e-06	7.01e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTGS2—urinary bladder cancer	2.22e-06	6.73e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EP300—urinary bladder cancer	2.2e-06	6.68e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	2.15e-06	6.52e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—SRC—urinary bladder cancer	2.14e-06	6.5e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	2.11e-06	6.39e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1A2—Metabolism—EP300—urinary bladder cancer	2.05e-06	6.22e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.04e-06	6.18e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	2.04e-06	6.18e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.02e-06	6.11e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	2.01e-06	6.1e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTGS2—urinary bladder cancer	1.95e-06	5.92e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.95e-06	5.91e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—PTEN—urinary bladder cancer	1.93e-06	5.87e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—MYC—urinary bladder cancer	1.92e-06	5.82e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.89e-06	5.74e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.89e-06	5.74e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—EGFR—urinary bladder cancer	1.88e-06	5.7e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.87e-06	5.68e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.87e-06	5.68e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.87e-06	5.66e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.87e-06	5.66e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Gene Expression—MYC—urinary bladder cancer	1.86e-06	5.64e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Metabolism—EP300—urinary bladder cancer	1.85e-06	5.6e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.84e-06	5.59e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	1.84e-06	5.58e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.81e-06	5.49e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.79e-06	5.44e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—KRAS—urinary bladder cancer	1.77e-06	5.38e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.76e-06	5.34e-05	CbGpPWpGaD
Conjugated Estrogens—SLCO1B1—Metabolism—EP300—urinary bladder cancer	1.75e-06	5.32e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.71e-06	5.17e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—PTEN—urinary bladder cancer	1.7e-06	5.16e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.65e-06	5.02e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.65e-06	5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.63e-06	4.93e-05	CbGpPWpGaD
Conjugated Estrogens—ABCG2—Metabolism—EP300—urinary bladder cancer	1.62e-06	4.92e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.62e-06	4.91e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.57e-06	4.77e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.55e-06	4.69e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.51e-06	4.59e-05	CbGpPWpGaD
Conjugated Estrogens—ABCC1—Disease—HRAS—urinary bladder cancer	1.51e-06	4.57e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.51e-06	4.57e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.51e-06	4.56e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.49e-06	4.53e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.49e-06	4.53e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.46e-06	4.44e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.46e-06	4.42e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.45e-06	4.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.43e-06	4.34e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.41e-06	4.26e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EP300—urinary bladder cancer	1.39e-06	4.21e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—SRC—urinary bladder cancer	1.35e-06	4.09e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.34e-06	4.07e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.32e-06	4.01e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.29e-06	3.91e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.26e-06	3.81e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.21e-06	3.67e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	1.18e-06	3.59e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.17e-06	3.54e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.15e-06	3.5e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.15e-06	3.5e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	1.12e-06	3.39e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.1e-06	3.35e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.08e-06	3.29e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.07e-06	3.25e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.06e-06	3.2e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.03e-06	3.12e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.02e-06	3.09e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—TP53—urinary bladder cancer	9.93e-07	3.01e-05	CbGpPWpGaD
Conjugated Estrogens—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	9.5e-07	2.88e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—PTEN—urinary bladder cancer	9.21e-07	2.79e-05	CbGpPWpGaD
Conjugated Estrogens—ABCB1—Metabolism—EP300—urinary bladder cancer	8.78e-07	2.66e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	8.43e-07	2.56e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.27e-07	2.51e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	7.94e-07	2.41e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—PTEN—urinary bladder cancer	7.35e-07	2.23e-05	CbGpPWpGaD
Conjugated Estrogens—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.01e-07	2.13e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.5e-07	1.97e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.67e-07	1.72e-05	CbGpPWpGaD
Conjugated Estrogens—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.41e-07	1.64e-05	CbGpPWpGaD
